5 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 5 of 5 clinical reviews.
How metformin pharmacokinetics, dosing patterns, and gastrointestinal tolerability appear to differ in East Asian populations, what is directly studied versus extrapolated, and what still needs specialist verification.
A guide to metformin dosing in Hispanic and Latino patients, covering pharmacogenomics, diabetes prevalence, ethnicity-stratified trial data, and practical dose titration protocols.
A clinical deep-dive into metformin pharmacogenomics, pharmacokinetics, and outcomes data specific to Black and African ancestry populations, including OCT1/OCT2 variants, renal considerations, and dosing guidance.
South Asian patients develop type 2 diabetes a decade earlier and at lower BMI than European patients. This guide covers metformin dosing, pharmacogenomics, and clinical protocols specifically for South Asian individuals, with evidence from major trials and ethnicity-stratified data.
How metformin's dosing, tolerability, and monitoring needs may differ for South Asian patients with type 2 diabetes, and what the underlying evidence does and does not establish.